Director's Dealing • Jun 8, 2018
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information
RNS Number : 7965Q
Spire Healthcare Group PLC
08 June 2018
8 June 2018
Spire Healthcare Group plc (the "Company")
Acquisition of Spire Healthcare shares by Peter Bamford
Peter Bamford, Deputy Chairman and Senior Independent Director of the Company, purchased 4,000 ordinary shares in the Company at a price of 248.0 pence each on 7 June 2018.
Following this announcement Mr Bamford holds a total of 9,000 ordinary shares which are held through an HSBC nominee account.
Enquiries:
Philip Davies
Deputy Company Secretary
020 7427 9092
The following disclosure is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||
| a) | Name | Peter Bamford | |
| 2 | Reason for the notification | ||
| a) | Position/status | Deputy Chairman and Senior Independent Director | |
| b) | Initial notification /Amendment | Initial notification | |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Spire Healthcare Group plc | |
| b) | LEI | 213800IBJPW3SE2RA350 | |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument Identification code |
Ordinary shares of 1 pence each | |
| b) | Nature of the transaction | Purchase of 4,000 ordinary shares at 248.0 pence each | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| 248.0 pence | 4,000 | ||
| d) | Aggregated information - Aggregated volume - Price |
As above | |
| e) | Date of the transaction | 2018-06-07 | |
| f) | Place of the transaction | XLON |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHBGGDLSDGBGII
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.